Veracyte executive sells shares in planned trade

Rhea-AI Filing Summary

VERACYTE, INC. Global Chief Commercial Officer John Leite reported an open-market sale of 13,975 shares of common stock on June 4, 2026 at a weighted average price of about $50.07 per share, executed under a pre-arranged Rule 10b5-1 plan. On June 2, 2026, 4,059 shares were withheld to satisfy tax obligations from vesting restricted stock units, which was not a market sale. Following these transactions, Leite directly holds 132,305 shares of Veracyte common stock.

Insider Trade Summary 10b5-1

Net Seller: 13,975 shares

Net Sell 2 txns

Insider Leite John

Role Global Chief Commercial Off

Sold 13,975 shs ($700K)

Type	Security	Shares	Price	Value
Sale	Common Stock	13,975	$50.0703	$700K
Exercise Price or Tax Liability	Common Stock	4,059	$47.80	$194K

Holdings After Transaction: Common Stock — 132,305 shares (Direct)

Footnotes (3)

1. F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.
2. F2. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2025.
3. F3. Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Key Figures

Open-market shares sold: 13,975 shares Weighted average sale price: $50.0703 per share Sale price range: $50.00 to $50.30 +3 more

6 metrics

Open-market shares sold 13,975 shares Common stock sale on June 4, 2026

Weighted average sale price $50.0703 per share Open-market sale on June 4, 2026

Sale price range $50.00 to $50.30 Price range for June 4, 2026 sales

Tax withholding shares 4,059 shares Withheld for RSU tax obligations on June 2, 2026

Tax withholding price $47.80 per share Value for tax-withholding disposition on June 2, 2026

Shares held after transactions 132,305 shares Direct common stock holdings after June 4, 2026 sale

Key Terms

Rule 10b5-1 plan, restricted stock units, tax withholding obligations, weighted average sales price

4 terms

Rule 10b5-1 plan financial

"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

restricted stock units financial

"in connection with the vesting of certain restricted stock units on June 2, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting"

weighted average sales price financial

"Represents weighted average sales price. Sale prices for the transactions range"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Veracyte (VCYT) report for John Leite?

Veracyte’s Global Chief Commercial Officer John Leite reported selling 13,975 shares of common stock in an open-market transaction and a separate 4,059-share tax withholding related to vesting restricted stock units, leaving him with 132,305 directly held shares after these transactions.

At what prices did John Leite’s Veracyte (VCYT) share sale occur?

John Leite’s open-market sale used a weighted average price of about $50.07 per share, with individual sale prices ranging from $50.00 to $50.30, according to the Form 4 disclosure and its accompanying weighted-average pricing footnote.

Was John Leite’s Veracyte (VCYT) stock sale part of a 10b5-1 trading plan?

Yes. The filing states the reported transactions were executed under a Rule 10b5-1 trading plan adopted by John Leite on June 9, 2025, indicating the sale was pre-arranged rather than a discretionary, opportunistic market decision at the time of execution.

How many Veracyte (VCYT) shares does John Leite hold after these Form 4 transactions?

After the reported sale and tax withholding disposition, John Leite directly owns 132,305 shares of Veracyte common stock, as shown in the post-transaction ownership column for the June 4, 2026 open-market sale entry in the Form 4 filing.

Did the 4,059 Veracyte (VCYT) shares reported with code F represent a sale?

No. The 4,059 shares marked with transaction code F were withheld solely to satisfy John Leite’s tax withholding obligations from vesting restricted stock units and, as the filing clarifies, this withholding does not constitute a market sale of shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 09:38 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leite John

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global Chief Commercial Off

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2026		F(1)		4,059	D	$47.8	146,280	D
Common Stock	06/04/2026		S(2)		13,975	D	$50.0703(3)	132,305	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.

2. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2025.

3. Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Remarks:

	/s/ Jonathan Wygant as attorney-in-fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)